WOCKPHARMANSEWockhardt Limited· PharmaceuticalsLowNeutral
Announced Mon, 2 Jun · 20:05 IST

Wockhardt Limited has informed the Exchange that Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company will hold an Investor meet/call on Thursday, 5th June, 2025 at 11:00 hrs IST through VC and in-person as detailed in the enclosed invite. The meeting/call will be initiated with a presentation by Dr. Murtaza Khorakiwala, Managing Director and will be followed by a Q&A Session in presence of Dr. Habil Khorakiwala, Chairman.

Board & Shareholder Meetings View source PDF

WOCKPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Wockhardt Limited has informed the stock exchanges that it will host an investor call on Thursday, 5th June 2025 at 11:00 AM IST, conducted both virtually and in-person. The session will begin with a presentation by Dr. Murtaza Khorakiwala, Managing Director, covering the company's performance and future business roadmap, followed by a Q&A session in the presence of Dr. Habil Khorakiwala, Chairman. Investors were invited to submit questions in advance by 4th June 2025, with in-person registration closing at 2:00 PM IST on 4th June 2025. The disclosure is filed under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Likely market impact

This is a routine investor engagement announcement with no immediate impact on stock price or shareholder value. Investors should watch for any new strategic or business updates that the management may share during the call on 5th June 2025.